Selective serotonin reuptake inhibitors vs placebo
Adverse events (nausea, dizziness) · chronic obstructive pulmonary disease (COPD) with depression
1 finding from 1 review
- Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease 2018 · Cochrane Headline outcomes onlyno estimate extracted3 studies · 171 participantsVery low